Research2Guidance November 4, 2024
Ralf-Gordon Jahns

Companion solutions have gained interest from pharma companies over the last few years. Hundreds of thousands of drugs could be supported with companion solutions. Enhancing adherence, identifying patients, and generating insights are levers to drive both drug sales and patient engagement. Six distinct types of companion solutions are preferred.

In recent years, we have seen pharmaceutical companies take a more short-term view of how they use digital technologies, including initiatives to support existing or to be launched medicines with digital solutions (companion solutions).

Companion solutions for drugs or medical devices are mobile or web applications designed to enhance treatment, improve patient outcomes, and assist healthcare providers in managing patient health. These include four essential components: the medication or medical device,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Pharma, Pharma / Biotech, Technology
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin
What might a Trump administration mean for the Biosecure Act?

Share This Article